Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » Q&A: Intermountain's Bert Lopansri Shares Perspective on PCR-Based Syndromic MDx Panels

Q&A: Intermountain's Bert Lopansri Shares Perspective on PCR-Based Syndromic MDx Panels

Apr 20, 2016
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – The clinical microbiology lab at Intermountain Healthcare serves as a routine lab for 16 hospitals — including a few with more than 350 beds — as well as some medium-sized hospitals, and it serves as a back-up lab for other hospitals in the system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

The Next Testing Hurdle

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

The Sturgeon Genome

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

For a Vaccine

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

Genome Biology Papers Look at Neuronal Epigenetics in Parkinson's, Differential Expression Method, More

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In PCR

  1. FDA Releases New EUA Guidance for MDx Labs Offering SARS-CoV-2 Testing

  2. Color Gears Up to Enter COVID-19 Testing Space

  3. Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

  4. Qiagen Receives FDA Emergency Use Authorization for SARS-CoV-2 Respiratory Panel

  5. Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.